Health ❯ Public Health ❯ Epidemiology ❯ Disease Prevention

Vaccination

Pfizer, Valneva Seek Approval for Lyme Vaccine After >70% Efficacy in Phase 3

Regulators will judge strong efficacy against limited case counts.

WHO Says Early H3N2 ‘Subclade K’ Flu Wave Is Straining Hospitals Across Europe

FDA Approves Two First-in-Class Oral Treatments for Gonorrhea

L.A. County Confirms Third Local Clade I Mpox Case as Officials Probe Possible Community Spread

UKHSA Renews Stay-Home Advice as Stratus and Nimbus Drive UK Covid Uptick

DR Congo Begins Ring Vaccination as Kasai Ebola Cases Rise